Surgical Resection With or Without Axillary Lymph Node Excision in Treating Menopausal Women With Infiltrative Breast Cancer Smaller Than 10 mm
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Overall Survival (5 years)
Antoine AVRIL, MD
Principal Investigator
Institut Bergonié
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
IB1995-28
NCT00210236
September 1995
December 2005
Name | Location |
---|